alirocumab
Ligand Summary
antibody to PCSK9 to manage LDL cholesterol
ChEMBL: CHEMBL2109540
DrugCentral: 5016
LyCHI: alirocumab
Target Activities
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | INHIBITOR | |||||